Research On COVID-19 Could Help Chronic Fatigue Syndrome Patients
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Research On COVID-19 Could Help Chronic Fatigue Syndrome Patients

We know that COVID-19 leaves some with long-lasting symptoms. In fact, we are beginning to discover the connection between the respiratory virus and chronic fatigue syndrome (CFS). Now, CFS patients…

Continue Reading Research On COVID-19 Could Help Chronic Fatigue Syndrome Patients
LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia
source: pixabay.com

LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia

The FDA grants designations, such as the Rare Pediatric Disease and Orphan Drug designations, to aid in the drug development process. Recently, LEXEO Therapeutics has received these two designations for…

Continue Reading LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia
Surufatinib Approved in China For the Treatment of Pancreatic Neuroendocrine Tumors
https://unsplash.com/photos/_jbClosDsD4

Surufatinib Approved in China For the Treatment of Pancreatic Neuroendocrine Tumors

The National Medical Products Administration (NMPA) of China has recently approved surufatinib for drug registration for the treatment of advanced pancreatic neuroendocrine tumors (pNETs). HUTCHMED Limited recently announced the news,…

Continue Reading Surufatinib Approved in China For the Treatment of Pancreatic Neuroendocrine Tumors